A randomized, double-blind, placebo and moxifloxacin (open-label) controlled, 4-period, crossover study of the effects of multiple oral doses of ERB-041 [prinaberel] on cardiac repolarization in healthy subjects

Trial Profile

A randomized, double-blind, placebo and moxifloxacin (open-label) controlled, 4-period, crossover study of the effects of multiple oral doses of ERB-041 [prinaberel] on cardiac repolarization in healthy subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 12 Apr 2007

At a glance

  • Drugs Prinaberel (Primary)
  • Indications Endometriosis; Rheumatoid arthritis
  • Focus Pharmacodynamics
  • Most Recent Events

    • 22 Nov 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top